
Purobien Lifesciences LLP
About Purobien Lifesciences LLP
Data last updated:
Purobien Lifesciences LLP was a limited liability partnership (LLP) based in New Delhi, Delhi, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 April 2018.
The LLP was registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAM-4394.
The LLP had a total obligation of contribution of ₹1 Lakh. It was led by designated partners Rajesh Kumar Pandey and Vijay Kumar Aggarwal.
Its latest statement of accounts is for the year ended 31 March 2019. The registered office was at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.
The LLP has about 33 employees on its provident fund (EPFO) records.
Company details
Contact details
Purobien Lifesciences LLP's registered office is in New Delhi, Delhi.
- Registered AddressPlot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Purobien Lifesciences LLP
FY 2019 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2018-19 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2018-19 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Purobien Lifesciences LLP, buy the company report.
Designated partners of Purobien Lifesciences LLP
Purobien Lifesciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Pandey | Designated Partner | 21 May 2019 | 7 Years 5 Months | As last reported |
| Vijay Kumar Aggarwal | Designated Partner | 17 Apr 2018 | 8 Years 7 Months | As last reported |
Legal cases
No court or tribunal cases involving Purobien Lifesciences LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Purobien Lifesciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Purobien Lifesciences LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Purobien Lifesciences LLP has 3 designated partner changes on record since 2018: 2 appointments and 1 cessation. The latest: Nidhi Aggarwal ceased to be Designated Partner on 21 May 2019.
Frequently asked questions
Purobien Lifesciences has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Purobien Lifesciences was a limited liability partnership based in New Delhi, Delhi, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 17 April 2018 and is registered under LLPIN AAM-4394. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Purobien Lifesciences is AAM-4394. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Purobien Lifesciences had 2 designated partners:
- Rajesh Kumar Pandey - Designated Partner
- Vijay Kumar Aggarwal - Designated Partner
Purobien Lifesciences was incorporated on 17 April 2018. It is registered with the Registrar of Companies, Delhi.
The registered office of Purobien Lifesciences is at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.
The latest financial statements of Purobien Lifesciences on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 31 March 2019. Year-wise statements from FY 2019 are in the company report.
Purobien Lifesciences operated in the pharma industry, in the drug formulation and development segment.
Nidhi Aggarwal ceased to be Designated Partner on 21 May 2019. Rajesh Kumar Pandey was appointed as Designated Partner on 21 May 2019. Vijay Kumar Aggarwal was appointed as Designated Partner on 17 Apr 2018.
Purobien Lifesciences can be reached at its registered office: Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.

